Schwetzingen, Germany

Rolf-Dieter Gabel

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: Roche Diagnostics Gmbh, Boehringer Mannheim Gmbh, Hoffmann-La Roche Inc.. Active years: 1996-2012.


% Patents Active = 84.6


 

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 286(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Rolf-Dieter Gabel: Innovator in Pharmaceutical Technology

Introduction

Rolf-Dieter Gabel is a notable inventor based in Schwetzingen, Germany. He has made significant contributions to the field of pharmaceutical technology, holding a total of 13 patents. His work focuses on improving the efficiency and safety of pharmaceutical preparations.

Latest Patents

One of Gabel's latest inventions is the "Transfer container for pharmaceutical recipients." This reusable container is designed for the sterile transfer of pharmaceutical recipients, particularly syringe bodies. It features an outer case and a sterilizable interior that is microbially isolated from the environment. The interior includes at least one holder for accommodating a nest that stores multiple pharmaceutical recipients. The container is equipped with a door for easy access to the nest and a lock that maintains sterility when coupled to a sterile space.

Another significant patent is related to "Carvedilol-galenics." This invention outlines a process for creating fast-dissolving pharmaceutical preparations from poorly soluble active substances. The process involves making an aqueous suspension of the active substance and water-soluble adjuvants, which is then processed to form solid pharmaceutical preparations. The resulting preparations have a dissolution rate of at least 70% after 30 minutes, showcasing their effectiveness.

Career Highlights

Throughout his career, Rolf-Dieter Gabel has worked with prominent companies in the pharmaceutical industry, including Roche Diagnostics GmbH and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Gabel has collaborated with notable professionals in the field, including Heinrich Woog and Walter Preis. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Rolf-Dieter Gabel's contributions to pharmaceutical technology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of effective pharmaceutical preparations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…